Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1184 participants.
Also called NCT06548971
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,184 participants
- Sponsor
- Registry
-
NCT06548971
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06548971. Randomized; quadruple masking; primary purpose treatment. Start 2024-11-07 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
- Acronym
- TREND-IVT
- Condition
- Acute Ischemic Stroke
- Condition
- Cerebral Infarction
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Placebo
- Intervention (Other)
- Best medical management
- Lead sponsor
- Capital Medical University
Record details
- Record id
cardio:ct-nct06548971- Content hash
52db7e7024648d4944a39aecc54e1ccde240335b77ca537c5cfa43f223dbab5f